OPGN (OTC)
OPGEN INC
$31.995000
+2.005000 (+6.69%)
Prev close: $29.990000
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Evan Jones
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $564.57M
- Employees
- 50
- P/E (TTM)
- —
- P/B (TTM)
- 2.40
- Dividend Yield
- 0.00%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $9.00M |
| Benefits Costs and Expenses | $1.98M |
| Costs And Expenses | $2.42M |
| Nonoperating Income/Loss | $440.90K |
| Operating Expenses | $2.42M |
| Operating Income/Loss | $6.58M |
| Income/Loss From Continuing Operations After Tax | $7.02M |
| Income/Loss From Continuing Operations Before Tax | $7.02M |
| Interest Expense, Operating | $12.02K |
| Net Income/Loss | $6.84M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $6.84M |
| Net Income/Loss Available To Common Stockholders, Basic | $6.70M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $117.58K |
| Preferred Stock Dividends And Other Adjustments | $1.16M |
| Basic Earnings Per Share | $0.18 |
| Diluted Earnings Per Share | $0.40 |
| Basic Average Shares | 21,959,950 |
| Diluted Average Shares | 31,958,329 |
| Assets | $12.64M |
| Current Assets | $5.52M |
| Noncurrent Assets | $7.12M |
| Fixed Assets | $966.23K |
| Other Non-current Assets | $6.15M |
| Liabilities | $2.48M |
| Current Liabilities | $782.50K |
| Accounts Payable | $307.78K |
| Wages | $25.44K |
| Other Current Liabilities | $449.28K |
| Noncurrent Liabilities | $1.70M |
| Equity | $10.16M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $10.16M |
| Liabilities And Equity | $12.64M |
| Net Cash Flow From Operating Activities | -$1.21M |
| Net Cash Flow From Operating Activities, Continuing | -$1.21M |
| Net Cash Flow From Investing Activities | $1.22M |
| Net Cash Flow From Investing Activities, Continuing | $1.22M |
| Net Cash Flow From Financing Activities | -$8.03K |
| Net Cash Flow From Financing Activities, Continuing | -$8.03K |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | $6.84M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $6.84M |
| Other Comprehensive Income/Loss | -$7.64M |